Literature DB >> 27021370

Effect of polyclonal activators on cytokine production by blood cells and by malignant breast cancer cells.

T A Kunts1, K V Karpukhina2, E S Mikhaylova2, I O Marinkin3, N A Varaksin4, A I Autenshlyus2, V V Lyakhovich2.   

Abstract

The production of cytokines by peripheral blood cells and biopsy specimens of tumors stimulated by polyclonal activators (PAs) was evaluated in 34 patients with invasive ductal breast carcinoma using enzyme-linked immunosorbent assay (ELISA). Positive correlation between the stimulation index of polyclonal activators (SIPA) for IL-18 production by the tumor and the relative content of poorly differentiated cells was revealed. The latter, in turn, was positively correlated with the numbers of normal and pathologic mitoses and the degree of malignancy. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27021370     DOI: 10.1134/S0012496616010026

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


  10 in total

Review 1.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

2.  Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

Authors:  Marina Lesina; Magdalena U Kurkowski; Katharina Ludes; Stefan Rose-John; Matthias Treiber; Günter Klöppel; Akihiko Yoshimura; Wolfgang Reindl; Bence Sipos; Shizuo Akira; Roland M Schmid; Hana Algül
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

Review 3.  Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?

Authors:  Hironori Tsujimoto; Satoshi Ono; Takashi Ichikura; Yusuke Matsumoto; Junji Yamamoto; Kazuo Hase
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

4.  Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines.

Authors:  K-E Kim; H Song; T S Kim; D Yoon; C-w Kim; S I Bang; D Y Hur; H Park; D-H Cho
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

5.  Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.

Authors:  Shalini Jain; Goutam Chakraborty; Remya Raja; Smita Kale; Gopal C Kundu
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells.

Authors:  Yukiko Ishida; Kiyoshi Migita; Yasumori Izumi; Kazuhiko Nakao; Hiroaki Ida; Atsushi Kawakami; Seigo Abiru; Hiromi Ishibashi; Katsumi Eguchi; Nobuko Ishii
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

7.  In vivo-like growth of human tumors in vitro.

Authors:  A E Freeman; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

Review 8.  Mechanics, malignancy, and metastasis: the force journey of a tumor cell.

Authors:  Sanjay Kumar; Valerie M Weaver
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

Review 9.  A tense situation: forcing tumour progression.

Authors:  Darci T Butcher; Tamara Alliston; Valerie M Weaver
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

10.  Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.

Authors:  Yan-Gao Man; Alexander Stojadinovic; Jeffrey Mason; Itzhak Avital; Anton Bilchik; Bjoern Bruecher; Mladjan Protic; Aviram Nissan; Mina Izadjoo; Xichen Zhang; Anahid Jewett
Journal:  J Cancer       Date:  2013-01-05       Impact factor: 4.207

  10 in total
  1 in total

1.  Cytokine production by the tumor from patients with breast cancer in different age groups.

Authors:  T A Kunts; E S Mikhaylova; I O Marinkin; N A Varaksin; A I Autenshlyus; V V Lyakhovich
Journal:  Dokl Biol Sci       Date:  2017-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.